China Life Insurance (02628): The China Banking and Insurance Regulatory Commission has approved the appointment of Hu Jin and Hu Rong as directors.

15/11/2024

GMT Eight

China Life Insurance (02628) announced that the company recently received approval from the China Banking and Insurance Regulatory Commission (CBIRC) for the appointment of Hu Jin and Hu Rong. According to the approval, the CBIRC has approved Hu Jin and Hu Rong to serve as directors of the company, with their appointments effective from November 14, 2024. On the same day, Hu Jin and Hu Rong will also serve as members of the Risk Management and Consumer Rights Protection Committee.

MOBI DEV (00947) repurchased 50,000 shares on November 15th.

ARTINI Holdings (00789) announces a happy profit, expecting a mid-term comprehensive surplus of approximately 1 million to 1.5 million Hong Kong dollars, turning a loss into a profit year-on-year.

Contact: contact@gmteight.com

China Life Insurance (02628): The China Banking and Insurance Regulatory Commission has approved the appointment of Hu Jin and Hu Rong as directors.

RECOMMEND

JUNSHI BIO (01877): Tislelizumab approved for marketing by the UK Medicines and Healthcare products Regulatory Agency

US Stock Market Move | Vanguard Group increases holdings in GameStop Corp. Class A (GME.US), pre-market trading up nearly 3%

CHINA HK POWER (00931) issued a profit warning, expecting a mid-term loss attributable to shareholders of approximately HK$50 million to HK$65 million.